Cancer risk in patients with Sjögren’s syndrome in Lithuanian cohort study
Clinical Rheumatology · 2025
DOI: 10.1007/s10067-025-07489-7 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Clinical Rheumatology, 2025. Verfasst von Gintarė Jonušienė und 6 weiteren Autor:innen. Beteiligte Einrichtung: Antakalnis Outpatient Clinic, LT-10207, Vilnius, Lithuania. gintare.jonusiene@gmail.com. Hauptthemen laut MEDLINE: Sjogren's Syndrome, Neoplasms. Die Arbeit nennt 18 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: Sjögren's syndrome (SjS) is a systemic autoimmune disease that predominantly affects the exocrine salivary and lacrimal glands, leading to the manifestation of classic symptoms-dry mouth and eyes. This study aims to analyze cancer risk by site among patients diagnosed with SjS using a Lithuanian population-based dataset. METHODS: The study cohort comprised all patients with an initial entry of Sjögren's syndrome (International Classification of Diseases Australian modification, ICD-10-AM diagnosis code M35.0) in the National Health Insurance Fund (NHIF) database, with the record of at least one prescription for antirheumatic medications in the NHIF database, recorded between 1 January 2012 and 31 December 2019. To determine cancer incidence within the cohort, we linked SjS records to the Lithuanian National Cancer Registry, incorporating data from the beginning of 2012 up to 31 December 2019, using personal identification numbers assigned to all Lithuanian citizens. RESULTS: In total, 29 males and 280 females diagnosed with SjS were included in the final analysis. The study found an increased risk of several cancers among female patients diagnosed with SjS. Notably, there was a statistically significant higher incidence rate of non-melanoma skin cancer (SIR 3.20, 95% CI [1.52-6.71]) and non-Hodgkin lymphoma (SIR 33.11, 95% CI [17.23-63.64]). Overall, the incidence of all cancers combined was also elevated (SIR 2.11, 95% CI [1.44-3.07]). CONCLUSIONS: Our study shows that there is a statistically significant increased risk of non-melanoma skin cancer and non-Hodgkin lymphoma among female patients diagnosed with Sjögren's syndrome compared to the general Lithuanian population. Key Points • The study found an increased risk of melanoma and non-Hodgkin lymphoma among female patients diagnosed with SjS. • The incidence of all cancers among female patients diagnosed with SjS was elevated. • There was an increased SIR for cancer diagnosis among patients exposed to bDMARDs during the follow-up period compared to those not exposed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Antakalnis Outpatient Clinic, LT-10207, Vilnius, Lithuania. gintare.jonusiene@gmail.com.
- Laboratory of Cancer Epidemiology, National Cancer Institute, 08406, Vilnius, Lithuania.
- Department of Thoracic Surgery and Oncology, National Cancer Institute, 08406, Vilnius, Lithuania.
- Department of Public Health, Institute of Health Sciences, Faculty of Medicine, Vilnius University, LT-03101, Vilnius, Lithuania.
- State Research Institute Centre for Innovative Medicine, 08409, Vilnius, Lithuania.
- Clinic of Rheumatology, Orthopaedics Traumatology and Reconstructive Surgery, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, 03101, Vilnius, Lithuania.
Zitieren
APA
Jonušienė, G., Kačėnienė, A., Gedvilaitė, V., Dadonienė, J., Miltinienė, D., Deresevičienė, G., & Smailytė, G. (2025). Cancer risk in patients with Sjögren’s syndrome in Lithuanian cohort study. Clinical Rheumatology. https://doi.org/10.1007/s10067-025-07489-7
Vancouver
Jonušienė G, Kačėnienė A, Gedvilaitė V, Dadonienė J, Miltinienė D, Deresevičienė G, et al. Cancer risk in patients with Sjögren’s syndrome in Lithuanian cohort study. Clinical Rheumatology. 2025. doi:10.1007/s10067-025-07489-7
BibTeX
@article{Jonuien2025,
author = {Jonušienė, Gintarė and Kačėnienė, Augustė and Gedvilaitė, Vaida and Dadonienė, Jolanta and Miltinienė, Dalia and Deresevičienė, Giedrė and Smailytė, Giedrė},
title = {Cancer risk in patients with Sjögren’s syndrome in Lithuanian cohort study},
journal = {Clinical Rheumatology},
year = {2025},
doi = {10.1007/s10067-025-07489-7}
}
EUVIMED